review Open Access
Multiple Sclerosis: A Review
BMJ · 1973 · Vol. 2(5863) · pp. 432–432
Abstract
5and 50% of patients will need help walking within 15 years after the onset of the disease. 6 Twice as many women are affected as men, and persons of Northern European descent appear to be at highest risk for MS. 2,7 The disease is diagnosed on the basis of clinical findings and supporting evidence from ancillary tests, such as magnetic resonance imaging (MRI) of the brain and examination of the cerebrospinal fluid (CSF). MS typically presents in adults 20 to 45 years of age; occasionally, it presents in childhood or late middle age. 7
Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsPrion Diseases and Protein MisfoldingMultiple sclerosisMagnetic resonance imagingMedicineDiseasePediatricsCerebrospinal fluidNeuroimagingNeurological examinationRadiologyPathology
Citations
496
FWCI
0.00
field-weighted impact
References
55
Percentile
11%
vs. same field & year
Citations per year
Cited by
The blood-brain barrier in aging and neurodegeneration
Molecular Psychiatry · 2022 · 628 citations
References
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Neurology · 1995 · 1,892 citations
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
Annals of Neurology · 2001 · 6,926 citations
Review: cytokines and the pathogenesis of multiple sclerosis
Journal of Neuroscience Research · 1996 · 328 citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Neurology · 1993 · 1,963 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
